Skip to main content
Log in

Inhibition of NO-dependent soluble human platelet guanylate cyclase by isatin

  • Published:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

Isatin (indole-dione-2,3) is an endogenous indole that exhibits a wide spectrum of biological and pharmacological activities. Physiologically relevant concentrations of isatin (ranged from 1 nM to 10 μM) did not influence basal activity of soluble human platelet guanylate cyclase (sGC), but caused a bell-shaped inhibition of the NO-activated enzyme. Inhibition of the NO-dependent activation by isatin did not depend on a chemical nature of the NO donors. The inhibitory effects of ODC (a heme-dependent inhibitor of sGC) and isatin were non-additive suggesting that the inhibitory effect of isatin may involve the heme binding domain (possibly heme iron) and experiments with hemin revealed some isatin-dependent changes in its spectrum. Isatin also inhibited sGC activation by the allosteric activator YC-1. It is suggested that the bell shaped inhibition of the NO-dependent activation of sGC by isatin may be attributed to complex interaction of isatin with the heme binding domain and the allosteric YC-1-binding site of sGC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Medvedev, A.E., Clow, A., Sandler M., and Glover, V., Biochem. Pharmacol., 1996, vol. 52, pp. 385–391.

    Article  CAS  Google Scholar 

  2. Medvedev, A.E., Igosheva, N., Crumeyrolle-Arias N., and Glover, V., Stress, 2005, vol. 8, pp. 175–183.

    Article  CAS  Google Scholar 

  3. Medvedev, A.E., Buneeva, O.A., and Glover, V., Biological Targets Therapeutics, 2007, vol. 1, pp. 151–162.

    CAS  Google Scholar 

  4. Glover, V., Medvedev, A.E., and Sandler, M., Life Sci., 1995, vol. 57, pp. 89–94.

    Article  Google Scholar 

  5. Medvedev, A.E., Sandler, M., and Glover, V., Life Sci., 1998, vol. 62, pp. 2391–2398.

    Article  CAS  Google Scholar 

  6. Binda, C., Li, M., Hubaler, F., Restelli, N., Edmondson, D.E., and Mattevi, A., Proc. Natl. Acad. Sci. USA, 2003, vol. 100, pp. 9750–9755.

    Article  CAS  Google Scholar 

  7. Medvedev, A.E., Bussygina, O.G., Pyatakova, N.V., Glover, V., and Severina, I.S., Biochem. Pharmacol., 2002, vol. 63, pp. 763–766.

    Article  CAS  Google Scholar 

  8. Ignarro L.J., Napoli C., and Loscalzo, J., Circ. Res., 2002, vol. 90, pp. 21–28.

    Article  CAS  Google Scholar 

  9. Kotz, A.Y., Martin, E., Sharina, I.G., and Murad, F., Hand Exp. Pharmacol., 2009, vol. 191, pp. 1–14.

    Article  Google Scholar 

  10. Hobbs, A.J., Br. J. Pharmacol., 2002, vol. 136, pp. 637–640.

    Article  CAS  Google Scholar 

  11. Stasch, J.P. and Hobbs, A.J., Hand Exp. Pharmacol., 2009, vol. 191, pp. 277–308.

    Article  CAS  Google Scholar 

  12. Chirkov, Yu.Yu., Tyshchuk, I.A., Belushkina, N.N., and Severina, I.S., Biokhimiya, 1987, vol. 52, pp. 956–963.

    CAS  Google Scholar 

  13. Garbers, D.S. and Murad, F., Adv.Cycl. Nucl. Res., 1979, vol. 10, pp. 57–67.

    CAS  Google Scholar 

  14. Bradford, H.M., Anal. Biochem., 1976, vol. 72, pp. 248–254.

    Article  CAS  Google Scholar 

  15. Bussygina, O.G., Pyatakova, N.V., Khropov, Yu.V., Ovchinnikov, I.V., Makhova, N.N., and Severina, I.S., Biochemistry (Moscow), 2000, vol. 65, pp. 457–462.

    CAS  Google Scholar 

  16. Schmidt, K., Schrammel, A., and Koesling, D., Mol. Pharmacol., 2001, vol. 59, pp. 220–224.

    CAS  Google Scholar 

  17. Friebe, A. and Koesling, D., Curculat. Res., 2003, vol. 93, pp. 96–106.

    Article  CAS  Google Scholar 

  18. Russwurm, M., Mergia, M., Mullershausen, E., and Koesling, D., J. Biol. Chem., 2002, vol. 277, pp. 24883–24888.

    Article  CAS  Google Scholar 

  19. Behrends, S., Curr. Med. Chem., 2003, vol. 10, pp. 291–301.

    CAS  Google Scholar 

  20. Bellamy, T.C. and Cartwaite, J., Br. J. Pharmacol., 2002, vol. 136, pp. 95–103.

    Article  CAS  Google Scholar 

  21. Evgenov, O.V., Pacher, P., Schmidt, P.M., Hasko, G., Schmidt, H.H.H., and Stasch, J.P., Rev. Drug Discov., 2006, vol. 5, pp. 755–768.

    Article  CAS  Google Scholar 

  22. Yazawa, S., Tsichiya, H., Hori, H., and Makino, R., J. Biol. Chem., 2006, vol. 281, pp. 21763–21770.

    Article  CAS  Google Scholar 

  23. Lamothe, M., Chang, F.J., Balashova, N., Shirokov, R., and Beuve, A., Biochemistry, 2004, vol. 43, pp. 3039–3048.

    Article  CAS  Google Scholar 

  24. Medvedev, A.E., Sandler, M., and Glover, V., Eur. J. Pharmacol., 1999, vol. 384, pp. 239–241.

    Article  CAS  Google Scholar 

  25. Mandal, P. and Ganguli, T., J. Phys.Chem. B, 2009, vol. 113, pp. 14904–14913.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. E. Medvedev.

Additional information

Original Russian Text © I.S. Severina, A.Yu. Schegolev, G.V. Ponomarev, A.E. Medvedev, 2011, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Severina, I.S., Schegolev, A.Y., Ponomarev, G.V. et al. Inhibition of NO-dependent soluble human platelet guanylate cyclase by isatin. Biochem. Moscow Suppl. Ser. B 5, 263–267 (2011). https://doi.org/10.1134/S1990750811030115

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750811030115

Keywords

Navigation